Skip to main content
United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
309.72
+8.33 (2.76%)
At close: Aug 13, 2025, 4:00 PM
308.73
-0.99 (-0.32%)
After-hours: Aug 13, 2025, 7:43 PM EDT

United Therapeutics Revenue by Segment
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Tyvaso
1.79B 1.71B 1.62B 1.56B 1.45B 1.37B 1.23B 1.13B
Tyvaso Growth
23.39% 25.33% 31.34% 38.18% 36.87% 45.60% 41.32% 41.17%
Remodulin
535.70M 548.30M 538.10M 518.70M 521.50M 501.40M 494.80M 502.20M
Remodulin Growth
2.72% 9.35% 8.75% 3.29% 7.50% 2.35% -1.08% 1.25%
Orenitram
465.60M 448.80M 434.30M 410.60M 389.40M 377.40M 359.40M 351.10M
Orenitram Growth
19.57% 18.92% 20.84% 16.95% 12.35% 14.19% 10.55% 9.17%
Unituxin
245.20M 238.50M 238.70M 225.40M 215.60M 208.20M 198.90M 181.40M
Unituxin Growth
13.73% 14.55% 20.01% 24.26% 22.36% 18.03% 8.75% -7.54%
Adcirca
24.20M 23.40M 23.80M 25.90M 26.20M 28.00M 28.90M 32.50M
Adcirca Growth
-7.63% -16.43% -17.65% -20.31% -27.02% -27.84% -30.02% -16.67%
Other
21.50M 20.90M 22.10M 20.50M 16.90M 14.50M 12.10M 18.20M - - - - - - - - - - - -
Other Growth
27.22% 44.14% 82.64% 12.64% - - - - - - - - - - - - - - - -

Revenue by Geography
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
United States
2.93B 2.85B 2.74B 2.62B 2.49B 2.37B 2.20B 2.08B
United States Growth
17.90% 19.96% 24.41% 25.96% 24.63% 26.68% 21.39% 19.78%
International
145.40M 146.30M 137.70M 136.30M 129.50M 124.30M 125.30M 124.30M
International Growth
12.28% 17.70% 9.90% 9.65% 12.32% 15.84% 2.54% 0.65%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.